P. Burgel (Sorbonne Paris Cité, France), C. Svanes (Bergen, Norway)
Late Breaking Abstract - Longitudinal progression of emphysema-like lung on CT in a general population study C. Pistenmaa (Boston, MA, United States of America), E. Hoffman (Iowa City, IA, United States of America), E. Angelini (New York, NY, United States of America), J. Yang (New York, NY , United States of America), A. Laine (New York, NY, United States of America), T. Vetterli (New York, NY, United States of America), B. Smith (New York, NY, United States of America), D. Lederer (New York, NY, United States of America), R. Barr (New York, NY, United States of America)
|    |
Late Breaking Abstract - Antibiotic treatment in acute exacerbation of COPD: patient outcomes with amoxicillin vs. amoxicillin/clavulanic acid - Data from 38,820 outpatients. K. Bagge (Hellerup, Denmark), F. Böetius Hertz (Herlev, Denmark), J. Victoria Eklöf (Hellerup, Denmark), P. Sivapalan (Hellerup, Denmark), J. Stæhr Jensen (Hellerup, Denmark)
|    |
Missed opportunity to manage COPD in patients hospitalised for heart failure C. Gulea (London, United Kingdom), R. Zakeri (London, United Kingdom), J. Quint (London, United Kingdom)
|    |
COPD phenotypes not linked to increased risk of coronary heart disease C. Svendsen (Bergen, Norway), T. Eagan (Bergen, Norway), P. Bakke (Bergen, Norway), R. Nielsen (Bergen, Norway), E. Nordeide (Bergen, Norway), V. Hodneland (Stord, Norway), K. Ostridge (Southampton, United Kingdom), T. Larsen (Bergen, Norway), K. Kuiper (Bergen, Norway)
|     |
Comparative metabolic and obesity profiles of COPD and non-COPD controls in the CanCOLD population-based cohort D. Viglino (Québec, Canada), M. Martin (Québec, Canada), C. Brouillard (Québec, Canada), J. Despres (Québec, Canada), N. Almeras (Québec, Canada), W. Tan (Vancouver, Canada), J. Pépin (Grenoble, France), J. Bourbeau (Montreal, Canada), F. Maltais (Québec, Canada)
|    |
Prognostic significance of respiratory symptoms in individuals with preserved pulmonary function without known airway disease Y. Çolak (Herlev, Denmark), B. Nordestgaard (Herlev, Denmark), J. Vestbo (Manchester, United Kingdom), P. Lange (Copenhagen, Denmark), S. Afzal (Herlev, Denmark)
|    |
Biochemical differences in patients with COPD due to tobacco and COPD by Biomass hospitalized in the intensive care unit. M. Escobar Penagos (Tuxtla Gutierrez, Mexico), K. Rivera Tovar (Ciudad de México, Mexico), E. Diaz Hernandez (Tuxtla Gutierrez, Mexico), E. Velazquez Martinez (Tuxtla Gutierrez, Mexico)
|  |
High prevalence of COPD among adults with heart disease B. Eriksson (Gothenburgh, Sweden), C. Stridsman (Umeå, Sweden), U. Nilsson (Umeå, Sweden), V. Strandkvist (Umeå, Sweden), H. Backman (Umeå, Sweden)
|    |